According to a different preclinical investigation, miR-21 increased tumor vascularization in prostate cancer cells by targeting the tumor suppressor PTEN, which then triggered the ERK1/2 and AKT signaling pathways and increased the production of VEGF and HIF-1 (200). This evidence concerns the gene VEGFA and prostate carcinoma.